Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
5.48 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.246 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.021 | 0.023 | 0.028 | 0.03 | 0.036 | 0.057 | 0.094 | 0.094 | 0.092 | 0.087 | 0.093 | 0.108 | 0.122 | 0.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.021 | -0.023 | 0.218 | -0.03 | -0.036 | -0.057 | -0.094 | -0.094 | -0.092 | -0.087 | -0.093 | -0.108 | -0.122 | -0.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.886 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 4.114 | 4.075 | 3.999 | 3.965 | 3.968 | 4.594 | 4.08 | 10.365 | 4.923 | 5.1 | 4.788 | 6.991 | 9.106 | 8.23 | 7.191 | 6.619 | 7.857 | 10.163 | 8.92 | 8.996 | 10.64 | 9.419 | 8.394 | 8.374 | 9.715 | 12.103 | 9.688 | 10.733 | 12.386 | 13.497 | 9.131 | 7.707 | 7.119 | 5.397 | 4.909 | 2.514 | 2.005 | 1.924 | 0.041 |
| General & Administrative Expenses
| 1.821 | 2.178 | 1.652 | 1.595 | 1.654 | 1.98 | 1.586 | 2.108 | 2.09 | 2.313 | 2.022 | 2.056 | 2.184 | 3.253 | 2.688 | 3.226 | 2.91 | 3.106 | 2.52 | 2.517 | 2.956 | 2.886 | 2.777 | 2.775 | 2.543 | 2.541 | 2.501 | 2.211 | 2.788 | 2.72 | 2.118 | 2.769 | 1.706 | 1.029 | 1.195 | 0.606 | 0.327 | 0.29 | 0.112 |
| Selling & Marketing Expenses
| -0.021 | -0.023 | -0.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.8 | 2.155 | 1.624 | 1.595 | 1.654 | 1.98 | 1.586 | 2.108 | 2.09 | 2.313 | 2.022 | 2.056 | 2.184 | 3.253 | 2.688 | 3.226 | 2.91 | 3.106 | 2.52 | 2.517 | 2.956 | 2.886 | 2.777 | 2.775 | 2.543 | 2.541 | 2.501 | 2.211 | 2.788 | 2.72 | 2.118 | 2.769 | 1.706 | 1.029 | 1.195 | 0.606 | 0.327 | 0.29 | 0.112 |
| Other Expenses
| 0 | 0 | 0.022 | 0 | 0 | 0.056 | 0.148 | 0.147 | 0.146 | 0.146 | 0.141 | 0.094 | 0 | 0 | 37.459 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.9 | 0.3 | 0 |
| Operating Expenses
| 5.914 | 6.23 | 5.623 | 5.56 | 5.622 | 6.574 | 5.666 | 12.473 | 7.013 | 7.413 | 6.81 | 9.047 | 11.29 | 11.483 | 9.879 | 9.845 | 10.767 | 13.269 | 11.44 | 11.513 | 13.596 | 12.305 | 11.171 | 11.149 | 12.258 | 14.644 | 12.189 | 12.944 | 15.174 | 16.217 | 11.249 | 10.476 | 8.825 | 6.426 | 6.104 | 3.12 | 2.332 | 2.214 | 0.154 |
| Operating Income
| -5.935 | -6.253 | -5.651 | -5.56 | -5.622 | -6.574 | -5.666 | -12.473 | -7.013 | -7.413 | -6.81 | -9.047 | -11.29 | -11.483 | -9.879 | -9.845 | -10.767 | -13.269 | -11.44 | -11.513 | -13.596 | -12.305 | -11.171 | -11.149 | -12.258 | -14.644 | -12.189 | -12.944 | -15.174 | -16.217 | -11.249 | -10.476 | -8.825 | -6.426 | -6.104 | -3.12 | -2.332 | -2.214 | -0.154 |
| Operating Income Ratio
| 0 | 0 | -22.972 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.673 | 0.552 | -1.002 | -0.865 | -1.284 | -1.299 | -4.15 | -2.358 | -1.35 | -0.884 | -2.418 | -1.615 | -0.463 | -0.1 | 37.225 | 0.049 | 0.156 | 0.334 | 0.393 | 0.509 | 0.618 | 0.662 | 0.662 | 0.651 | 0.627 | 0.343 | 0.26 | 0.227 | 0.193 | 0.181 | 0.164 | 0.179 | 0.18 | 0.079 | 0.065 | -0.031 | -17.9 | 0.3 | 0 |
| Income Before Tax
| -4.262 | -5.701 | -6.653 | -6 | -6.503 | -7.873 | -9.816 | -14.831 | -8.363 | -8.297 | -9.236 | -10.673 | -11.752 | -11.58 | 27.347 | -9.796 | -10.611 | -12.935 | -11.047 | -11.004 | -12.978 | -11.643 | -10.509 | -10.498 | -11.631 | -14.301 | -11.929 | -12.717 | -14.981 | -16.036 | -11.086 | -10.297 | -8.645 | -6.347 | -6.039 | -3.151 | -20.232 | -1.913 | -0.154 |
| Income Before Tax Ratio
| 0 | 0 | -27.045 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.02 | -0.095 | -0.425 | -0.403 | 0.923 | 6.384 | -0.225 | -0.1 | 0.884 | 0.008 | -1.604 | -0.001 | -0.003 | -0.143 | 0 | 0 | 0 | -0.185 | -0.186 | 0 | 0 | -0.18 | 0 | 0 | 0 | -0.219 | 0 | 0 | 0 | -0.184 | 0 | 0 | 0 | 17.6 | 0 | 0 | -0.001 | 0 |
| Net Income
| -4.262 | -5.701 | -6.653 | -6 | -6.503 | -8.796 | -16.2 | -14.606 | -8.263 | -9.181 | -9.236 | -10.673 | -11.752 | -11.58 | 27.347 | -9.796 | -10.611 | -12.935 | -11.047 | -11.004 | -12.978 | -11.643 | -10.509 | -10.498 | -11.631 | -14.301 | -11.929 | -12.717 | -14.981 | -16.036 | -11.086 | -10.297 | -8.645 | -6.347 | -6.039 | -3.151 | -20.232 | -1.913 | -0.154 |
| Net Income Ratio
| 0 | 0 | -27.045 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.071 | -0.12 | -0.14 | -0.12 | -0.14 | -0.19 | -0.35 | -0.31 | -0.18 | -0.2 | -0.2 | -0.24 | -0.28 | -0.34 | 0.92 | -0.33 | -0.36 | -0.44 | -0.38 | -0.37 | -0.44 | -0.4 | -0.36 | -0.36 | -0.4 | -0.63 | -0.58 | -0.62 | -0.73 | -0.79 | -0.55 | -0.51 | -0.43 | -5.39 | -0.68 | -0.15 | -0.99 | -0.094 | -0.49 |
| EPS Diluted
| -0.071 | -0.12 | -0.14 | -0.12 | -0.14 | -0.19 | -0.35 | -0.31 | -0.18 | -0.2 | -0.2 | -0.24 | -0.28 | -0.34 | 0.92 | -0.33 | -0.36 | -0.44 | -0.38 | -0.37 | -0.44 | -0.4 | -0.36 | -0.36 | -0.4 | -0.63 | -0.58 | -0.62 | -0.73 | -0.79 | -0.55 | -0.51 | -0.43 | -5.39 | -0.68 | -0.15 | -0.99 | -0.094 | -0.49 |
| EBITDA
| -5.914 | -6.23 | -5.623 | -5.53 | -5.586 | -6.574 | -5.688 | -12.379 | -6.921 | -7.326 | -9.228 | -10.554 | -11.168 | -11.346 | -9.879 | -9.698 | -10.608 | -13.085 | -11.44 | -11.513 | -13.41 | -12.119 | -11.171 | -10.921 | -12.038 | -14.425 | -12.189 | -12.733 | -14.966 | -16.013 | -11.249 | -10.317 | -8.681 | -6.32 | 11.553 | -3.065 | -2.297 | -2.213 | 0 |
| EBITDA Ratio
| 0 | 0 | -22.858 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |